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Background: In 1986, Japanese Association for Thoracic Surgery
started a nationwide survey of the number of primary lung cancer
undergoing resection and this survey was continued annually. There-
after, investigations of lung cancer surgical results have been con-
ducted three times. The postoperative overall 5-year survival rate
was 47.8% in resected cases in 1989, 52.3% in 1994, and 62.0% in
1999, showing improvement over the decade (p  0.01).
Objective: To clarify the factors influencing survival improvements
retrospectively.
Patients and Methods: The subjects of the investigation are the
patients who underwent resection for primary lung cancers in 1989,
1994, and 1999. Postoperatively, after 5 years, surveys of surgical
results were sent to institutes where lung cancer resection had been
performed. The subjects undergoing resection who provided 10
items (age, sex, pathologic T factor, pathologic N factor, pathologic
M factor, date of resection, histology, curability, prognosis, and
survival time) numbered 3004 in 1989, 6895 in 1994, and 12,235 in
1999. They were classified according to the Union International
Contre le Cancer 1997 revised tumor, node, and metastasis classi-
fication. Differences in age, gender, histology, pathologic stage,
curability, and operative death rates were analyzed for each survey
year.
Results: According to the changes in proportions, the cases over 70
years of age, women, and pathologic stage I increased significantly
(p  0.001), whereas in cases with small cell lung cancer, incom-
plete resection and operative death decreased significantly over time
(p  0.001).
Conclusion: The postoperative 5-year survival rate in Japan im-
proved between 1989 and 1999. The main cause of this improve-
ment was the increase in early stage lung cancer, especially cases
with tumors 2 cm or less in size.
Key Words: Lung cancer, Resection, 5-year survival rate, Survival
index, Improvement.
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The Japanese Association for Thoracic Surgery (JATS)started surveying the number of primary lung cancer
patients undergoing resection and their histologic types, for
patients whose tumors were resected in 1986 at 556 institu-
tions in Japan. The number of lung cancer patients undergo-
ing resection in 1986 was reported to be 6421.1 The survey
has been continued annually and reached 26,531 patients in
2006.2 As for postoperative long-term survival results, The
Japanese Association for Chest Surgery (JACS) investigated
the 5-year survival rate of patients who were operated on for
lung cancer in 1989 after 5 years of follow-up on a large scale
for the first time in Japan. Shirakusa reported the overall
5-year survival rate to be 47.2%.3 The Japan Lung Cancer
Society and the JACS then established an ad hoc task force,
the Japanese Joint Committee of Lung Cancer Registry, to
perform a retrospective study on the prognosis and clinico-
pathological profiles of patients receiving lung cancer resec-
tion in 1994 and 1999. The overall 5-year survival rate was
52.6% in resected cases in 19944 and 61.4% in 1999.5 Herein,
we performed a retrospective analysis of factors influencing
survival improvement in patients undergoing resection for
lung cancer during the 1989–1999 decade.
PATIENTS AND METHODS
The subjects of the investigation are the patients who
underwent resection of primary lung cancer in 1989, 1994,
and 1999. Postoperatively, after 5 years, surveys on surgical
results were sent to institutes where lung cancer operations
had been performed. Though the Academic Investigation
Committee of JATS accumulated the data from 7607 lung
cancer patients who were operated on in 1989 in Japan, JACS
performed a survey on the survival rate of patients undergo-
ing resection in 1989 by sending a questionnaire to the
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society member’s institutions and received 3643 responses.
We used the 3004 patients’ data, which were completely
equipped with the necessary items (Table 1). The patients
who were operated on in 1994 and 1999, as documented by
the Japanese Joint Committee of Lung Cancer Registry that
was established by JATS and JACS, were surveyed at the
institutions of the councilors of JATS and JACS. According
to the questionnaire, data from 22,134 patients included all 10
items (age, sex, pathologic T factor, pathologic N factor,
pathologic M factor, date of resection, histology, curability,
prognosis, and survival time). These patients were thus the
subjects of this study. Based on the operative specimens, all
patients were pathologically classified according to the Union
International Contre le Cancer (UICC) 1997 revised tumor,
node, and metastasis classification.6 The patients of this study
numbered 3004 who underwent resection in 1989, 6895 in
1994, and 12,235 in 1999.
Statistical Analysis
Survival time was measured from the date of resection
to the date of the most recent follow-up examination, at the
time of questionnaire survey. Survival was calculated by the
Kaplan-Meier method, and differences in survival were as-
sessed by log-rank analysis. The proportion tendency by de-
cade was examined using the Cochran-Armitage trend test. A p
value less than 0.05 was considered statistically significant.
RESULTS
There were 36,130 patients in total who underwent
resection at three times, 1989, 1994, and 1999, in Japan, and
22,134 patients (61.3%) were eligible for this study. Men
accounted for 74% cases in 1989 but only 67% in 1999. As
to histologic type, adenocarcinoma cases accounted for 49%
in 1989 but had increased to 63% in 1999. As to pathologic
stage, stage I case was 48% in 1989, but rates increased to
52% in 1994 and 59% in 1999. The postoperative overall
5-year survival rate was 47.8% in 1989, 52.3% in 1994, and
62.0% in 1999 (Fig. 1). The 5-year survival rates improved
over the decade and there were significant differences among
the three survival curves (p  0.01). Six factors which
contributed to the postoperative survival, age, gender, histo-
logic type, pathologic stage, curability, and operative death
rate, are shown in Table 2.
FIGURE 1. Postoperative overall survival curve. The 5-year survival rate improved over the decade and there were significant
differences among the three groups (p  0.01).
TABLE 1. Patient Characteristics
Year of Resection 1989 1994 1999
Number of resected patients 7607 11,227 17,296
Number of survey 3643 7408 13,344
Number of study subjects 3004 6895 12,235
Age mean  SD (yr) 63.7  9.9 64.4  9.8 65.8  9.8
Gender (%)
Male/female 74/26 70/30 67/33
Histological type (%)
Ad/Sq/La/Sm/others 49/37/6/4/4 56/33/4/3/4 63/28/4/2/3
Pathological stage (%)
I/II/III/IV 48/16/31/5 52/15/29/4 59/14/24/3
Number of resected patients: Annual survey by The Japanese Association for
Thoracic Surgery.
Ad, adeno carcinoma; Sq, squamous cell carcinoma; La, large-cell carcinoma; Sm,
small-cell carcinoma.
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The proportion of cases more than 70 years of age was
29.9% in 1989, increased gradually, and exceeded 40% in
1999. The 5-year survival rates of both age groups were
improved over the decade. The proportion of women in-
creased and the 5-year survival rates of both gender groups
were improved over the decade. As to histology, the propor-
tion of non-small cell lung cancer (NSCLC) increased and the
5-year survival rates of both NSCLC and small cell lung
cancer (SCLC) groups were improved over the decade. As to
pathologic stage, the proportion of stage I cases increased but
the proportions of stages II, III, and IV decreased over the
decade. In terms of curability, the proportion of incomplete
resections decreased but the 5-year survival rates of both
complete and incomplete resection groups were improved
over the decade. The proportion of operative deaths was 1.7%
in 1989, 1.3% in 1994, and 0.9% in1999, showing a decrease
over the decade. According to the changes in proportions,
those over 70 years age, women, and pathologic stage I cases
increased significantly (p  0.001), whereas in SCLC cases,
incomplete resections and operative deaths decreased signif-
icantly over the decade (p  0.001) (Table 3). According to
the pathologic stage subtype, the proportion of cases and its
5-year survival rates are shown in Table 4. The proportion of
stage I cases increased about 12% from 47.7% in 1989,
51.8% in 1994, and finally to 59.4% in 1999. Because there
was little change in the proportion of stage I B cases, the main
cause of the increase was the higher proportion the stage I A
cases. As for the 5-year survival rate, for all groups other than
stage 0 and stage II B in 1994, the 5-year survival rates
improved over the decade. As for the improvement in the
5-year survival rate from 1989 to 1999, we used the survival
index to confirm which substaging groups contributed to this
change. We multiplied the proportion by the 5-year survival
rate of the each of the staging groups and used this figure as
the survival index. Therefore, the total of the survival index
for each stage (0–IV) served as the 5-year survival rate of
each period. The 5-year survival rate was 47.8% in 1989,
meaning that if 100 patients were operated on, 47.8 patients
were alive 5 years after resection and the survival index
showed that 20 of these 47.8 patients had stage I A, 12.7 stage
I B, 1.4 stage II A, 5.8 stage II B, 5.5 stage III A, 1.3 stage
III B, and 0.7 stage IV (Table 5). Because the survival index
of stage I A increased 12.0, from 20.0 in 1989 to 32.0 in 1999,
the main cause of the 5-year survival rate improvement was
the increase in the stage I survival index, meaning that other
stage groups did not contribute to the improvement of 5-year
survival rates for all cases. Stage I A cases were then divided
into two groups with tumor diameters of 2 cm or less versus
more than 2 cm. We compared the cases undergoing resection
in 1994 and 1999, because tumor size was not included
among the questionnaire items in 1989. The survival index of
TABLE 3. Proportion of Cases According to Potential
Prognostic Factors
Year of Resection 1989 1994 1999 p
Over 70 yr old (%) 29.9 32.5 40.9 0.0001
Female (%) 26.1 30.1 33.0 0.0001
Pathological stage I (%) 47.7 51.8 59.4 0.0001
SCLC (%) 3.7 3.2 2.4 0.0001
Incomplete resection (%) 12.9 11.5 8.6 0.0001
Operative death (%) 1.7 1.3 0.9 0.0001
SCLC, small cell lung cancer.
TABLE 2. Proportions of Cases and 5-yr Survival Rates According to Potential Prognostic Factors
Year of Resection
Variable
1989 (n  3004) 1994 (n  6895) 1999 (n  12,235)
Proportion (%) 5-yr Survival (%) Proportion (%) 5-yr Survival (%) Proportion (%) 5-yr Survival (%)
Age
70 yr 70.1 51.1 67.5 55.6 59.1 66.8
70 yr 29.9 40.1 32.5 45.3 40.9 54.8
Gender
Male 73.9 43.6 69.9 48.2 67.0 55.8
Female 26.1 59.8 30.1 61.8 33.0 74.6
Histological type
NSCLC 96.3 48.3 96.8 52.9 97.6 62.5
SCLC 3.7 34.8 3.2 35.2 2.4 43.5
Pathological stage
0 0.5 71.4 0.02 50.0 0.4 89.5
I 47.7 68.7 51.8 71.5 59.4 77.7
II 15.9 45.0 15.4 46.2 13.6 50.6
III 31.0 22.0 29.3 24.7 23.7 31.9
IV 4.9 13.8 3.5 19.8 2.9 24.3
Curability
Complete resection 87.1 53.2 88.5 56.6 91.4 65.2
Incomplete resection 12.9 11.4 11.5 18.0 8.6 27.2
Operative death 1.7 0 1.3 0 0.9 0
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.
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stage I A cases increased 7.9, from 24.1 in 1994 to 32.0 in
1999 (Table 6). Because those cases with tumors of 2 cm or
less in size had a proportion rate of 6.2% among a total 7.9%
increase in stage I A cases, and those with tumors larger than
2 cm were 1.7%, the main cause of the increase was the
patients with tumors of 2 cm or less. Furthermore, in cases
with tumors of 2 cm or less, the improvement in the 5-year
survival rate was only 3.0% from 1994 to 1999, i.e., the main
cause of the increase in the survival index was the 6.6%
increase in this proportion. The main reason for the 5-year
survival rate of stage I cases increasing 6.2%, from 71.5% in
1994 to 77.7% in 1999, was the increase in the proportion of
cases with tumors of 2 cm or less.
DISCUSSION
There have been reports on lung cancer postoperative
results but those describing more than 1000 cases are few
(Table 7). Mountain reported the 5-year survival rate of 1910
NSCLC cases according to pathologic staging.7 The overall
5-year survival rate of all cases, as calculated by our group,
was 48.9%. The 5-year survival rate after resection was
42.6% according to Naruke et al.8 and 41.4% according to
van Rens et al.9 Pfannschmidt et al.10 reported that the 5-year
survival rate of undergoing resection at Heidelberg Univer-
sity, from 1996 to 2005, was 46.8%. Goldstraw et al.11
reported the 5-year survival rate of 15,952 NSCLC cases
according to pathologic staging and the overall 5-year sur-
vival rate of all cases, as calculated by our group, was 46.9%.
It is not unexpected that postoperative survival changes
with each decade based on the date of resection, histology,
postoperative death rates, and the distribution of stages.
However, as the 5-year survival rates of this study in 1994
and 1999 exceeded 50%, good surgical results for lung cancer
appeared to have been achieved. There have been a few
reports of surgical results focusing on changes over time.
Koike et al. divided the date of resection into three periods
based on differences in lung cancer mass screening system
and reported that the proportion of stage I A cases increased
and that the 5-year survival rate improved over time with the
spread of the lung cancer mass screening system (Table 8).12
Fang and coworkers compared the NSCLC surgical results in
four periods: 1960s, 1970s, 1980s, and 1990s. They reported
that the 5-year survival rate improved with some influencing
factors, such as the rate of postoperative complications,
lymph node dissection, and combination therapy.13 Yoshino
and coworkers compared the surgical results of NSCLC
resected in the three decades from 1975 to 1998 and reported
that the 5-year survival rates improved with each decade due
to an increasing population of female patients with adenocar-
cinoma, more frequency detection of early disease, and ef-
fective elimination of unresectable cases.14 In this study, the
postoperative 5-year survival rate in Japan improved from
1989 to 1994 and 1999, mainly due to an increased propor-
tion of females and pathologic stage I cases, and decreased
proportions of incomplete resections and postoperative
deaths.
TABLE 4. Proportion of Patients and 5-yr Survival Rate According to Pathological Staging
Year of Resection
1989 (n  3004) 1994 (n  6895) 1999 (n  12,235)
Proportion (%) 5-yr Survival (%) Proportion (%) 5-yr Survival (%) Proportion (%) 5-yr Survival (%)
Pathological stage
0 0.5 71.4 0.02 50.0 0.4 89.5
I A 26.4 75.8 30.3 79.5 38.2 83.7
I B 21.3 59.8 21.5 60.1 21.2 66.6
II A 2.9 48.8 3.6 58.0 3.1 59.9
II B 13.0 44.2 11.8 42.6 10.5 47.8
III A 22.3 24.6 18.8 27.2 15.0 32.8
III B 8.7 15.3 10.5 20.1 8.7 30.3
IV 4.9 13.8 3.5 19.8 2.9 24.3
Total 100.0 47.8 100.0 52.3 100.0 62.0
TABLE 5. Survival Index According to Pathological Staging
Year of Resection
1989
(n  3004)
1994
(N  6895)
1999
(n  12,235)
5-yr survival rate (%) 47.8 52.3 62.0
0 0.4 0.0 0.4
I A 20.0 24.1 32.0
I B 12.7 13.0 14.2
II A 1.4 2.1 1.9
II B 5.8 5.1 5.1
III A 5.5 5.1 5.0
III B 1.3 2.2 2.7
IV 0.7 0.7 0.7
TABLE 6. Pathological Stage IA Patients
Year of Resection
Tumor
Size (cm)
Proportion
(%)
5-yr
Survival
Rate (%)
Survival
Index
1994 I A 30.3 79.5 24.1
2.0 16.6 82.4 13.7
2.1–3.0 13.7 75.6 10.4
1999 I A 38.2 83.7 32.0
2.0 23.2 85.4 19.9
2.1–3.0 14.9 80.8 12.1
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As to factors influencing postoperative survival in mul-
tivariate analysis, Fang et al. insisted that tumor, node, and
metastasis staging and the curability of resection influenced
survival,13 while Yoshino and coworkers reported that the
increase in the proportion of complete resections, or in
patients less than 70 years old or female or with stage I,
influenced long-term survival.14 In our study, a negative
factor, the proportion of those more than 70 years old, was
found to be increased over the decade, but positive factors
such as the increase in the proportion of females and early
stage diagnosis, and decreases in SCLC and operative-deaths,
improved the survival rate with each decade. As to the change
in the 5-year survival rate by substaging group, the survival
rate improvement was noted in all subgroups except stage 0
and stage II B in 1994. However, the greatest change in the
survival index was in stage I A. As the increase in the survival
index in stage I A from 1989 to 1999 was 12.0 points, this
was the main contributor to the improvement in the 5-year
survival rate of all case from 47.8% in 1989 to 62.0% in
1999. As to the improvement in the stage I A survival rate,
we divided stage I A cases from 1994 and 1999 into those
with tumors of 2 cm or less and those with 2.1–3.0 cm
tumors, and compared these two groups. In the 2.0 cm or
less group, because the 5-year survival rates were only
slightly different, the increase in this proportion contrib-
uted markedly to increase in the survival index.
In Japan, a nationwide lung cancer mass screening
program provided by the Health and Medical Services Law
for the Aged started in 1987 with plain chest radiographs and
sputum cytology for unemployed residents.15 The number of
people screened for lung cancer has been increasing and now
exceeds 7,000,000 per year in Japan, and the number of lung
cancers detected is about 3600 (detection rate; 0.051%).16 It
seems that the spread of this lung cancer mass screening
system has contributed to the increase in stage I A cases.
In conclusion, the postoperative 5-year survival rate in
Japan has improved from 47.8% in 1989 to 52.3% in 1994
and finally 62.0% in 1999. The main cause of this improve-
ment is the increase in detection of early stage lung cancers,
especially tumors of 2 cm or less in size.
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